BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11857074)

  • 1. The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target.
    Yamada Y; Pannell R; Forster A; Rabbitts TH
    Oncogene; 2002 Feb; 21(9):1309-15. PubMed ID: 11857074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional control of fetal liver hematopoiesis: dominant negative effect of the overexpression of the LIM domain mutants of LMO2.
    Terano T; Zhong Y; Toyokuni S; Hiai H; Yamada Y
    Exp Hematol; 2005 Jun; 33(6):641-51. PubMed ID: 15911088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nestin-linked green fluorescent protein transgenic nude mouse for imaging human tumor angiogenesis.
    Amoh Y; Yang M; Li L; Reynoso J; Bouvet M; Moossa AR; Katsuoka K; Hoffman RM
    Cancer Res; 2005 Jun; 65(12):5352-7. PubMed ID: 15958583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice.
    Yamada Y; Pannell R; Forster A; Rabbitts TH
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):320-4. PubMed ID: 10618416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the key LMO2-binding determinants on Ldb1.
    Ryan DP; Sunde M; Kwan AH; Marianayagam NJ; Nancarrow AL; Vanden Hoven RN; Thompson LS; Baca M; Mackay JP; Visvader JE; Matthews JM
    J Mol Biol; 2006 May; 359(1):66-75. PubMed ID: 16616188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Lim-only protein LMO2 acts as a positive regulator of erythroid differentiation.
    Hansson A; Zetterblad J; van Duren C; Axelson H; Jönsson JI
    Biochem Biophys Res Commun; 2007 Dec; 364(3):675-81. PubMed ID: 17964543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bv8 regulates myeloid-cell-dependent tumour angiogenesis.
    Shojaei F; Wu X; Zhong C; Yu L; Liang XH; Yao J; Blanchard D; Bais C; Peale FV; van Bruggen N; Ho C; Ross J; Tan M; Carano RA; Meng YG; Ferrara N
    Nature; 2007 Dec; 450(7171):825-31. PubMed ID: 18064003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of LMO2 expression in the progression of prostate cancer.
    Ma S; Guan XY; Beh PS; Wong KY; Chan YP; Yuen HF; Vielkind J; Chan KW
    J Pathol; 2007 Feb; 211(3):278-85. PubMed ID: 17167821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Of mice and men: how an oncogene transgresses the limits and predisposes to T cell acute lymphoblastic leukemia.
    Hoang T
    Sci Transl Med; 2010 Mar; 2(21):21ps10. PubMed ID: 20374994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A postulated role for transcriptional regulator LMO2 in the proliferation and involution of hemangioma.
    Sun ZJ; Zhang L; Zhao YF
    Med Hypotheses; 2006; 67(5):1230-2. PubMed ID: 16793212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the lmo2 promoter during hematopoietic and vascular development in zebrafish.
    Zhu H; Traver D; Davidson AJ; Dibiase A; Thisse C; Thisse B; Nimer S; Zon LI
    Dev Biol; 2005 May; 281(2):256-69. PubMed ID: 15893977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells.
    Grütz GG; Bucher K; Lavenir I; Larson T; Larson R; Rabbitts TH
    EMBO J; 1998 Aug; 17(16):4594-605. PubMed ID: 9707419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
    Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
    Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LMO2 promotes angiogenesis probably by up-regulation of bFGF in endothelial cells: an implication of its pathophysiological role in infantile haemangioma.
    Sun ZJ; Cai Y; Chen G; Wang R; Jia J; Chen XM; Zheng LW; Zhao YF
    Histopathology; 2010 Oct; 57(4):622-32. PubMed ID: 20955387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hepatitis C virus internal ribosome entry site facilitates efficient protein synthesis in blood vessel endothelium during tumour angiogenesis.
    Chung GT; Yamada Y; Pannell R; Forster A; Rabbitts TH
    Nucleic Acids Res; 2003 Apr; 31(8):e46. PubMed ID: 12682381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
    Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice.
    Goto H; Yano S; Zhang H; Matsumori Y; Ogawa H; Blakey DC; Sone S
    Cancer Res; 2002 Jul; 62(13):3711-5. PubMed ID: 12097279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of angiogenesis by Abeta peptides.
    Paris D; Townsend K; Quadros A; Humphrey J; Sun J; Brem S; Wotoczek-Obadia M; DelleDonne A; Patel N; Obregon DF; Crescentini R; Abdullah L; Coppola D; Rojiani AM; Crawford F; Sebti SM; Mullan M
    Angiogenesis; 2004; 7(1):75-85. PubMed ID: 15302999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
    Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
    Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.